drug development tool

(5)The term “drug development tool” includes— (A)a biomarker; (B)a clinical outcome assessment; and (C)any other method, material, or measure that the Secretary determines aids drug development and regulatory review for purposes of this section.

Source

21 USC § 357(e)(5)


Scoping language

In this section
Is this correct? or